Roche: Supportive clinical data of already-approved cancer drugs and PD-L1 product

NEUTRAL, Fair Value CHF252 (+3%)

News published on September Monday 30, 2013
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities